Dear Colleague |
Please find correspondence HERE from Kathryn Turner, Pharmacy Lead, Strategic Planning and Performance Group. |
SUMMARY
- Existing supplies of aQIV in Community Pharmacies must be prioritised for vaccinations of the remaining Care Home resident population. For patients aged 65 years and over not in care homes, where aQIV is unavailable, QIVc may be offered as an alternative.
- From today, all quotas of aQIV will be set to zero and any requests for aQIV must be authorised in advance by SPPG.
- Requests for additional aQIV will only be approved if the stock is required for vaccination of Care Home residents.
- Requests for additional aQIV to meet the needs of Care Home residents should be sent to Deirdre McAree (Deirdre.mcaree@hscni.net) or Greg Miller (Greg.Miller@hscni.net) stating the number of vaccines required and the Care Home to be vaccinated.
- If a patient is eligible for the aQIV vaccine, and the pharmacy does not have any stock it is acceptable to offer QIVc.
- This is covered within the PGD, service specification and JCVI guidance.
- If patients aged 65 years and over decline QIVc and wish to avail of aQIV, they should be signposted to another pharmacy that has stock, or to their registered GP.
- Patients should be informed of the preferred vaccination for their cohort.
ACTION
- Contractors are asked to review the correspondence.
- SPPG have asked community pharmacy contractors and pharmacists involved in the service to assess current aQIV stock levels to ensure there is sufficient quantities to vaccinate all remaining Care Home residents, and ringfenced for use in Care Home resident population.
- SPPG have asked community pharmacy contractors and pharmacists involved in the service to use any surplus for those 65 years and over presenting in the pharmacy.
- If you have any queries in relation to any elements of this service, please contact Deirdre McAree (Deirdre.mcaree@hscni.net) or Greg Miller (Greg.Miller@hscni.net).
- Please contact the CPNI office should you require any further information.
Kind regards

GERARD GREENE
Chief Executive